Warrants for the arrest of pharmaceutical industry executives have been issued in Venezuela as part of criminal investigations into alleged drug overpricing.
Judge Cristobal Ramiraz of the Caracas criminal court has issued 16 arrest warrants so far, and says his investigations will spread further. Most of the executives named in the warrants have voluntarily presented themselves to the judge, and are currently out on bail. Among those arrested is Raul Mejuto, pharmaceutical director for Ciba-Geigy in Venezuela, and also president of the Venezuelan multinational pharmaceutical industry association CAVEME.
Also among those arrested are executives working for a number of multinational pharmaceutical companies in Venezuela, including Eli Lilly, Merck, Sharp & Dohme, Servier, Sandoz, Hoffmann-La Roche, Bayer and Rhone-Poulenc. There are 36 overseas-owned drug firms in the country. Additionally implicated are executives from some of Venezuela's national pharmaceutical companies, including Leti, Farma, Klinos, Biotech, and Spefar.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze